» Articles » PMID: 38590781

The Influence of Birthweight on Mortality and Severe Neonatal Morbidity in Late Preterm and Term Infants: an Australian Cohort Study

Overview
Date 2024 Apr 9
PMID 38590781
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to detail incidence rates and relative risks for severe adverse perinatal outcomes by birthweight centile categories in a large Australian cohort of late preterm and term infants.

Methods: This was a retrospective cohort study of singleton infants (≥34 weeks gestation) between 2000 and 2018 in Queensland, Australia. Study outcomes were perinatal mortality, severe neurological morbidity, and other severe morbidity. Categorical outcomes were compared using Chi-squared tests. Continuous outcomes were compared using t-tests. Multinomial logistic regression investigated the effect of birthweight centile on study outcomes.

Findings: The final cohort comprised 991,042 infants. Perinatal mortality occurred in 1944 infants (0.19%). The incidence and risk of perinatal mortality increased as birthweight decreased, peaking for infants <1st centile (perinatal mortality rate 13.2/1000 births, adjusted Relative Risk Ratio (aRRR) of 12.96 (95% CI 10.14, 16.57) for stillbirth and aRRR 7.55 (95% CI 3.78, 15.08) for neonatal death). Severe neurological morbidity occurred in 7311 infants (0.74%), with the highest rate (19.6/1000 live births) in <1st centile cohort. There were 75,243 cases of severe morbidity (7.59% livebirths), with the peak incidence occurring in the <1st centile category (12.3% livebirths). The majority of adverse outcomes occurred in infants with birthweights between 10 and 90th centile. Almost 2 in 3 stillbirths, and approximately 3 in 4 cases of neonatal death, severe neurological morbidity or other severe morbidity occurred within this birthweight range.

Interpretation: Although the incidence and risk of perinatal mortality, severe neurological morbidity and severe morbidity increased at the extremes of birthweight centiles, the majority of these outcomes occurred in infants that were apparently "appropriately grown" (i.e., birthweight 10th-90th centile).

Funding: National Health and Medical Research Council, Mater Foundation, Royal Australian College of Obstetricians and Gynaecologists Women's Health Foundation - Norman Beischer Clinical Research Scholarship, Cerebral Palsy Alliance, University of Queensland Research Scholarship.

Citing Articles

Perinatal mortality and other severe adverse outcomes following planned birth at 39 weeks versus expectant management in low-risk women: a population based cohort study.

Crawford K, Carlo W, Odibo A, Papageorghiou A, Tarnow-Mordi W, Kumar S EClinicalMedicine. 2025; 80:103076.

PMID: 39927106 PMC: 11803212. DOI: 10.1016/j.eclinm.2025.103076.


RidStress 2 randomised controlled trial protocol: an Australian phase III clinical trial of intrapartum sildenafil citrate or placebo to reduce emergency caesarean birth for fetal distress in women with small or suboptimally grown infants at term....

Triggs T, Badawi N, Crawford K, Liley H, Lehner C, Nugent R BMJ Open. 2024; 14(9):e082945.

PMID: 39322593 PMC: 11425951. DOI: 10.1136/bmjopen-2023-082945.


Impact of Clinical Use of Probiotics on Preterm-Related Outcomes in Infants with Extremely Low Birth Weight.

Wu W, Chiang M, Fu R, Lai M, Wu I, Lien R Nutrients. 2024; 16(17).

PMID: 39275310 PMC: 11397160. DOI: 10.3390/nu16172995.


The influence of antenatal betamethasone timing on neonatal outcome in late preterm infants: a single-center cohort study.

Bruckner T, Redlich A Arch Gynecol Obstet. 2024; .

PMID: 39249517 DOI: 10.1007/s00404-024-07714-9.


The Relationship between Placental Shear Wave Elastography and Fetal Weight-A Prospective Study.

Cavanagh E, Crawford K, Hong J, Fontanarosa D, Edwards C, Wille M J Clin Med. 2024; 13(15).

PMID: 39124699 PMC: 11313635. DOI: 10.3390/jcm13154432.

References
1.
Akolekar R, Ciobanu A, Zingler E, Syngelaki A, Nicolaides K . Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Am J Obstet Gynecol. 2019; 221(1):65.e1-65.e18. DOI: 10.1016/j.ajog.2019.03.002. View

2.
Badawi N, Keogh J . Causal pathways in cerebral palsy. J Paediatr Child Health. 2013; 49(1):5-8. DOI: 10.1111/jpc.12068. View

3.
Wilson E, Wastlund D, Moraitis A, Smith G . Late Pregnancy Ultrasound to Screen for and Manage Potential Birth Complications in Nulliparous Women: A Cost-Effectiveness and Value of Information Analysis. Value Health. 2021; 24(4):513-521. DOI: 10.1016/j.jval.2020.11.005. View

4.
Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F . FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021; 152 Suppl 1:3-57. PMC: 8252743. DOI: 10.1002/ijgo.13522. View

5.
Morales-Rosello J, Khalil A, Morlando M, Bhide A, Papageorghiou A, Thilaganathan B . Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio. Ultrasound Obstet Gynecol. 2014; 45(2):156-61. DOI: 10.1002/uog.14647. View